Neurological Disease Diagnostics Case Study (Huntington's & Alzheimer's Disease): Quantifying the Impact of Improved Biomarkers on Drug Sales

Zapisane w:
Opis bibliograficzny
Format: Elektroniczne E-book
Wydane: Marketline 2008
Dostęp online:Available in Business Source Ultimate.
Ver en el OPAC
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

MARC

LEADER 00000nam a22000002 4500
001 ebs56805049e
003 EBZ
006 m d ||||||
007 cr|unu||||||||
008 251205nuuuuuuuuxx |||| o|||||||||||||||d
035 |a (EBZ)ebs56805049e 
040 |a EBZ 
042 |a msc 
050 0 0 |a   
130 0 |a Neurological Disease Diagnostics Case Study (Huntington's & Alzheimer's Disease): Quantifying the Impact of Improved Biomarkers on Drug Sales (Online) 
245 0 0 |a Neurological Disease Diagnostics Case Study (Huntington's & Alzheimer's Disease): Quantifying the Impact of Improved Biomarkers on Drug Sales  |h [electronic resource]. 
260 |b Marketline  |c 2008 
773 0 |t Business Source Ultimate   |d EBSCO 
856 4 0 |3 Full text available: Jul 2008.  |z Available in Business Source Ultimate.  |u https://biblioteca.ues.edu.sv/acceso/ebsco/?url=https%3A%2F%2Fsearch.ebscohost.com%2Fdirect.asp%3Fdb%3Dbsu%26jid%3D8P21%26scope%3Dsite 
901 |a Case Study